Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes
2011

Study of Pathway Involved in Eye Disorders

Sample size: 43 publication Evidence: moderate

Author Information

Author(s): Abu El-Asrar Ahmed M., Missotten Luc, Geboes Karel

Primary Institution: King Saud University

Hypothesis

The HMGB1/RAGE/OPN/Egr-1 pathway may be involved in the pathogenesis of proliferative vitreoretinal disorders.

Conclusion

The HMGB1/RAGE/OPN/Egr-1 pathway may be involved in inflammatory, angiogenic, and fibrotic responses in proliferative vitreoretinal disorders.

Supporting Evidence

  • In PDR membranes, vascular endothelial cells expressed HMGB1, RAGE, OPN, and Egr-1 in 21, 15, 20, and 16 membranes, respectively.
  • The numbers of blood vessels and stromal cells expressing CD34, HMGB1, RAGE, and OPN were significantly higher in active membranes than in inactive membranes.
  • Significant correlations were detected between the number of blood vessels expressing CD34 and the number of blood vessels and stromal cells expressing HMGB1, RAGE, and OPN.

Takeaway

This study looked at how certain proteins in the eye might be causing problems in people with serious eye diseases related to diabetes.

Methodology

Immunohistochemistry was used to study 9 active and 13 inactive membranes from patients with PDR and 21 membranes from patients with PVR.

Limitations

The study is based solely on immunohistochemical detection of these molecules in epiretinal membranes.

Participant Demographics

Patients with proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication